Why is JSS a strategic partner for your COVID-19 study development?

JSS COVID-19 Task Force


  • We have designated a team which keeps abreast of the latest developments pertaining to SARS-CoV-2

  • We have a deep understanding and are fully aware of the challenges involved in the current treatment processes and testing protocols according to the regulations of various states and provinces

  • Scientific Affairs Group
    • COVID-19 Standard of Care and Competing Studies
    • COVID-19 Synopsis and Protocol Templates

  • Feasibility
    • We are securing potential sites
    • We are remaining up-to-date with changing patient availability
    • We are aware of differentiations between Hospitals (Canada vs US), CHSLDs, Long-Term Care facilities and SMOs

Biotechnology companies face a unique set of challenges. Product development is an expensive and time-consuming process with no guarantees of achieving commercialization. Access to capital is a constraint and most companies require external resources such as CROs to conduct their clinical trials.

A CRO with the right skills and knowledgeable project teams can make all the difference. JSS Medical Research understands what it takes to work with biotechnology firms.

For our biotech clients the evolution from local mid-size Canadian CRO to a niche global CRO will provide them with access to patients and high quality research sites on several continents that will facilitate the completion of their clinical development programs.